3/4
07:07 pm
tlsa
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial [Yahoo! Finance]
High
Report
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial [Yahoo! Finance]
3/4
08:00 am
tlsa
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
Medium
Report
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
2/27
08:00 am
tlsa
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury
High
Report
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury
2/25
09:34 am
tlsa
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter [Yahoo! Finance]
2/25
08:00 am
tlsa
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
Medium
Report
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
2/21
09:42 am
tlsa
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC [Yahoo! Finance]
2/21
08:19 am
tlsa
Tiziana Life Sciences enters product development services pact with Renaissance Lakewood [Seeking Alpha]
Medium
Report
Tiziana Life Sciences enters product development services pact with Renaissance Lakewood [Seeking Alpha]
2/21
08:00 am
tlsa
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
High
Report
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
2/18
09:11 am
tlsa
Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program [Yahoo! Finance]
2/18
08:00 am
tlsa
Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program
High
Report
Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program
2/11
10:39 am
tlsa
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease [Yahoo! Finance]
2/11
09:15 am
tlsa
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
Low
Report
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
1/23
03:00 pm
tlsa
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
Medium
Report
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
1/23
08:54 am
tlsa
Tiziana Life Sciences not to engage in capital raising activities for the immediate future
High
Report
Tiziana Life Sciences not to engage in capital raising activities for the immediate future
1/22
04:50 pm
tlsa
Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab [Yahoo! Finance]
1/22
04:05 pm
tlsa
Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab
Medium
Report
Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab
1/10
08:00 am
tlsa
Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
High
Report
Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
1/8
07:00 am
tlsa
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
Low
Report
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
12/17
07:32 am
tlsa
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer's Disease Dosed with Intranasal Foralumab [Yahoo! Finance]
Low
Report
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer's Disease Dosed with Intranasal Foralumab [Yahoo! Finance]
12/17
07:00 am
tlsa
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
Low
Report
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab